BIOMAT Database Logo BIOMAT Database Logo

Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives. 2010

Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Department of Pharmaceutical Chemistry, AISSMS College of Pharmacy, Kennedy Road, Pune, Maharashtra, India. drugdesign1@gmail.com

Most non-steroidal anti-inflammatory drugs (NSAIDs) suffer from the deadlier gastrointestinal (GI) toxicities. The free -COOH group is responsible for the GI toxicity associated with all traditional NSAIDs. In the present research work, the main objective was to develop new chemical entities as potential anti-inflammatory agents with no GI toxicities. The results of synthesis and pharmacological screening of a series of hybrid molecules having general formula 2-(5-(5-(substituted phenyl)-2-oxo-ethylthio)-1,3,4-oxadiazole-2-yl)-2-phenyl-1H-indol-1-yl)-2-oxoethyl nitrate are described. These compounds were tested in vivo for their anti-inflammatory, analgesic, and ulcerogenic properties, and subjected to histopathological studies. Compound 7c, 2-(5-(5-(3-hydroxyphenyl)-2-oxo-ethylthio)-1,3,4-oxadiazole-2-yl)-2-phenyl-1H-indol-1-yl)-2-oxoethyl nitrate, was the most potent in this series. The compounds that showed significantly reduced GI ulcerogenicity also showed promising results in histopathological studies, and they were found to cause no mucosal injury. All the synthesized compounds were found to exhibit significant nitric oxide releasing activity in an in vitro method. In conclusion, the designed hybrid molecules were found to be significantly promising.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D005767 Gastrointestinal Diseases Diseases in any segment of the GASTROINTESTINAL TRACT from ESOPHAGUS to RECTUM. Cholera Infantum,Gastrointestinal Disorders,Functional Gastrointestinal Disorders,Gastrointestinal Disorders, Functional,Disease, Gastrointestinal,Diseases, Gastrointestinal,Functional Gastrointestinal Disorder,Gastrointestinal Disease,Gastrointestinal Disorder,Gastrointestinal Disorder, Functional
D000700 Analgesics Compounds capable of relieving pain without the loss of CONSCIOUSNESS. Analgesic,Anodynes,Antinociceptive Agents,Analgesic Agents,Analgesic Drugs,Agents, Analgesic,Agents, Antinociceptive,Drugs, Analgesic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000894 Anti-Inflammatory Agents, Non-Steroidal Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. Analgesics, Anti-Inflammatory,Aspirin-Like Agent,Aspirin-Like Agents,NSAID,Non-Steroidal Anti-Inflammatory Agent,Non-Steroidal Anti-Inflammatory Agents,Nonsteroidal Anti-Inflammatory Agent,Anti Inflammatory Agents, Nonsteroidal,Antiinflammatory Agents, Non Steroidal,Antiinflammatory Agents, Nonsteroidal,NSAIDs,Nonsteroidal Anti-Inflammatory Agents,Agent, Aspirin-Like,Agent, Non-Steroidal Anti-Inflammatory,Agent, Nonsteroidal Anti-Inflammatory,Anti-Inflammatory Agent, Non-Steroidal,Anti-Inflammatory Agent, Nonsteroidal,Anti-Inflammatory Analgesics,Aspirin Like Agent,Aspirin Like Agents,Non Steroidal Anti Inflammatory Agent,Non Steroidal Anti Inflammatory Agents,Nonsteroidal Anti Inflammatory Agent,Nonsteroidal Anti Inflammatory Agents,Nonsteroidal Antiinflammatory Agents
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014456 Ulcer A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue. Ulcers
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Novel nitric oxide-releasing derivatives of brusatol as anti-inflammatory agents: design, synthesis, biological evaluation, and nitric oxide release studies.
September 2014, Journal of medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Novel nitric oxide-releasing derivatives of triptolide as antitumor and anti-inflammatory agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
March 2020, European journal of medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Analgesic, anti-inflammatory and antiulcer activity of nitric oxide releasing ester derivatives of indomethacin.
January 2010, Indian journal of physiology and pharmacology,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
December 2022, European journal of medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Indomethacin Analogs: Synthesis, Anti-inflammatory and Analgesic Activities of Indoline Derivatives.
January 2018, Mini reviews in medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Synthesis of novel 4-substituted-7-trifluoromethylquinoline derivatives with nitric oxide releasing properties and their evaluation as analgesic and anti-inflammatory agents.
October 2005, Bioorganic & medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Synthesis and investigation of anti-inflammatory activity and gastric ulcerogenicity of novel nitric oxide-donating pyrazoline derivatives.
July 2009, European journal of medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Design, synthesis, and biological evaluation of novel nitric oxide releasing dehydroandrographolide derivatives.
October 2018, Chinese journal of natural medicines,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
3-methyl-2-phenyl-1-substituted-indole derivatives as indomethacin analogs: design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents.
January 2016, Journal of enzyme inhibition and medicinal chemistry,
Shashikant V Bhandari, and Jignesh K Parikh, and Kailash G Bothara, and Trupti S Chitre, and Deepak K Lokwani, and Titiksh L Devale, and Nileema S Modhave, and Vidya S Pawar, and Santosh Panda
Design, Synthesis, and Biological Evaluation of Some Novel Pyrrolizine Derivatives as COX Inhibitors with Anti-Inflammatory/Analgesic Activities and Low Ulcerogenic Liability.
February 2016, Molecules (Basel, Switzerland),
Copied contents to your clipboard!